Rik van Heijningen
No más puestos en curso
Perfil
Rik van Heijningen is a Director of ART Advanced Research Technologies, Inc. Prior to joining ART Advanced Research Technologies, Mr. van Heijningen held various sales, marketing and business leadership positions at Kreatech Biotechnology BV, including Interim Vice President Commercial Operations.
He held various leadership positions at Invitrogen BV and Dynal Biotech ASA. Mr. van Heijningen spent the last 20 years in the research, discovery and preclinical market arena.
He held various sales, marketing and business leadership positions at Dynal Biotech LLC, including Senior Sales Manager, General Manager of Germany and Interim Vice President of Tissue Typing.
Mr. van Heijningen was a Clinical Oncology Research Technician at the Academic Hospital of the Free University.
He received an MBA from the University of Birmingham, England and completed university studies in biochemistry.
Antiguos cargos conocidos de Rik van Heijningen.
| Empresas | Cargo | Fin |
|---|---|---|
| ART ADVANCED RESEARC | Director/Miembro de la Junta | - |
Formación de Rik van Heijningen.
| University of Birmingham | Masters Business Admin |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
| Empresas privadas | 1 |
|---|---|
ART Advanced Research Technologies, Inc.
 ART Advanced Research Technologies, Inc. Medical SpecialtiesHealth Technology ART Advanced Research Technologies, Inc. designs, develops and markets laser and thermal imaging technologies. The firm offers products in medical imaging, medical diagnostics, disease research, and drug discovery areas. It provides Optix MX2, a preclinical optical imaging device; and Optix OptiView, a software tool that helps researchers manage and analyze data collected on the Optix acquisition system. The company was founded on July 13, 1993 and is headquartered in Saint-Laurent, Canada. | Health Technology |
- Bolsa de valores
- Insiders
- Rik van Heijningen
